Altimmune Inc. (ALT)
NASDAQ: ALTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.66 0.00%
ALT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $517.42M
- EPS (TTM)
- -$0.76
- Dividend yield
- None
- 52-week range
- 2.56 – 6.44
- Day range
- 2.63 – 2.74
- Volume / Avg
- 3.16M / 4.19M
- Beta
- —
- Shares outstanding
- 194.52M
- Next earnings
- Nov 5, 2026
52-week range
ALT stock today
On Oct 7, ALT ended the session at $2.66, shedding $0.01 (0.37%), versus the S&P 500's 0.22% decline. Shares are 58.7% below their 52-week high of $6.44, set on Jan 23, 2026 and 3.9% above the 52-week low of $2.56, near the bottom of the past year's range. ALT is down 26.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 32.3%.
Altimmune has posted a net loss over the last twelve months (EPS of -$0.76), so its P/E ratio is not meaningful. Altimmune's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Altimmune
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.14
ALT news
All ALT newsAltimmune peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MPLTMapLight Therapeutics Inc. | 9.36 | -3.41% | $520.19M | vs ALT |
| NGNENeurogene Inc. | 25.87 | +1.65% | $517.69M | vs ALT |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs ALT |
| DRUGBright Minds Biosciences Inc. | 52.00 | +7.77% | $512.93M | vs ALT |
| EOLSEvolus Inc. | 7.74 | +4.88% | $511.23M | vs ALT |
| BLSMBlossomHill Therapeutics Inc. | 16.61 | -3.93% | $527.95M | vs ALT |
| PBYIPuma Biotechnology Inc | 9.81 | +3.26% | $506.39M | vs ALT |
| CBIOCrescent Biopharma Inc. | 13.49 | -0.59% | $501.11M | vs ALT |
Indexes, lists and sector
Altimmune stock FAQ
What is Altimmune's stock price today?
ALT last traded at $2.66 as of Oct 7, 4:00 PM EDT, down 0.37% on the day. Prices are delayed at least 15 minutes.
Does Altimmune pay a dividend?
No. Altimmune does not currently pay a regular cash dividend.
When is Altimmune's next earnings date?
Altimmune is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.14.
Has ALT ever split its stock?
Yes. The most recent ALT stock split was a 1-for-30 split on Sep 14, 2018.
What is the ALT 52-week high?
The 52-week high for ALT is $6.44 and the 52-week low is $2.56. The stock is currently 58.7% below its high.